The site-selective incorporation of ncAAs into peptidesa nd proteins in vivo can be achieved throught he suppression of a stop codon by the action of an orthogonal translation system (OTS, Figure1A). [1] [2] [3] An OTS is comprised of an engineered aminoacyl tRNA synthetase (aaRS),w hich loads an cAA ontoi ts corresponding tRNA, while none of the OTS components interacts with endogenousamino acids, aaRSs or tRNAs (= orthogonal, Figure 1B) . [4] The incorporation of ncAAsb ya nO TS is achieved if:1 )protein engineering efforts have changed the cognate substrate preference of the aaRS to an cAA of choice, and 2) the tRNA features the anticodon sequence (e.g.,C UA) to a stop codon, for example, UAG ( Figure 1A) . Charged tRNAs are then recruited to the ribosome, where in-frame UAG stop codons in mRNAs are suppressed,r esulting in the site-selective incorporation of an cAA into the nascent peptidec hain. Despite typically modest suppression efficiencies and the fact that not every ncAA is genetically encodable (metabolic stability,l imited uptake, etc.), this strategy has provene xceptionally versatile. [3, 4] Indeed, more than 150 ncAAsh ave been successfully incorporated into peptides and proteins of interest in a variety of model organisms. Since its conception more than 15 years ago, stop codon suppression as as trategy has predominantly been applied fori ntroducing ncAAs with functional groups that enable site-selective protein modification and/or elucidating, altering or regulating protein function. [3, 5] However,m ore recently, OTSs have also been repurposedf or other tasks. This Concept article will highlight recent developments for which ncAA incorporation has proven particularly impactful and is divided into three sections:1 )Selection, 2) Addiction, and 3) Catalysis.
Selection:n cAAs in Peptide Macrocyclization
Macrocyclic peptides (MPs) are privileged scaffolds for the development of chemical probesa nd therapeutics. [6, 7] Combining ah igh degree of functional complexity with ar estricted conformational flexibility make MPs well-suited to achieve tight binding to notoriously difficult targets,s uch as biomolecular interfaces. [8] Moreover,p eptidem acrocyclization is as traightforward meanst or educe protease degradation and can facilitate cellular uptake. [9] Lastly,peptides are genetically encodable and lend themselves to massive parallel screening and selection efforts that allow for identifying tight bindersf rom randomized populations. As ar esult, methodst og enetically encodeMPlibraries are sought after,yet the number of cyclization strategies-and therefore, the accessible ring geometries-remain limited. [10] Bioactive MPs found in nature often feature ncAAs and utilize unique functionalities placed in their side chains to promote macrocyclization. [11] In an effort to mimic such natural products,t he Suga group has led efforts to encode MPs containingawide variety of ncAAs in vitro. [12] Ta king advantage of well-defined, reconstituted translation systems, in which natural aaRS/tRNA pairs are replaced with synthetically pre-charged tRNAs featuring non-standardb uilding blocks, [13] the group Expanding the geneticc ode of organisms by incorporating noncanonicala mino acids (ncAAs) into target proteins through the suppressiono fs top codons in vivo has profoundly impacted how we performp rotein modification or detect proteins and their interaction partnersi nt heir native environment. Yet, with genetic code expansion strategies maturingo ver the past 15 years, new applications that make use-or indeed repurpose-these techniques are beginning to emerge. This
Concepta rticle highlights three of these developments:1 )The incorporation of ncAAs for the biosynthesisa nd selection of bioactive macrocyclic peptides with novel ring architectures, 2) synthetic biocontainments trategies based on the addiction of microorganisms to ncAAs, and 3) enzyme design strategies, in which ncAAsw ith unique functionalities enable the catalysis of new-to-nature reactions. Key advances in all three areas are presenteda nd potential future applications discussed.
generated MPs with up to eleven ncAAs in their sequence. [14] Placing uniquelyr eactive functional groupsi ntheir side chains facilitated the installation of novel ring geometries that could be interfaced with traditional mRNA display [15] and allowed for selectiono fM Pi nhibitors againstavariety of targetp roteins. [12] Performing analogouse xperiments in vivo is significantly more challenging, as multiple, chemically distinct ncAAs cannotr eliably be incorporated simultaneously.M oreover,c yclization strategies need to be compatible with the plethora of reactive groups inside the producing organism.N evertheless, in vivo strategies are desirable,a st hey can be linked to phenotypic screens or selection against potential targets in their native environment. [12, 16, 17] Efforts toward developing such strategies have been led by the Fasan group, who began utilizing ncAAs with unique functionalities to access MPs from genetically encoded,y et purified peptides. [18] [19] [20] [21] Guided by these efforts, the group established as et of criteria an cAA needs to fulfill to enablec yclization in vivo. [22] First, suitable ncAAs should be amenable to incorporation through stopc odon suppression,afact that limits their structures tyrosine and pyrrolysine analogues, as OTSs based on aaRSs for these amino acids are currently most advanced. Moreover,f unctionalities introduced by ncAAs need to be sufficiently reactive to undergo cyclization with an earby canonical amino acid in the same peptide, but not too reactive to undergo side reactions with competing moleculesi nt he cellular milieu. With these criteria in mind the Fasan group identified aromatic ncAAsf eaturing either an appropriate nucleophile or leaving group as candidates to promote peptidem acrocyclization in vivo (Figure 2A and B). [22, 23] For example, introducing 3-(2-mercaptoethyl)aminophenylalanine( MeaF,F igure 2C)a llowed cyclization in the presence of aC -terminal GyrAi ntein. [23] Inteins transiently form thioesters, which are prone to undergo substitution reactions in the presence of appropriate nucleophiles (Figure 2A) . Specifically, MP formation in the presence of MeaF is at wo-step process: first, at ransthioesterification, promoted by the nucleophilic sulfhydryl group of MeaF( p K a 8.5), yields at hiolactone,w hich then undergoes an irreversible S!Na cyl transfer to yield the desired N-alkyl macrolactam( see Flag-cyclo(Strep3) in Figure 2D for an example of the structure formed). Rather unexpected, the latter step was found to be rate-determining in vivo and MPs (N > 4i nF igure 2A)c ould only be isolated after extended production times in Escherichia coli (24 hours). Critically,Fasan and co-workers showed that MPs obtained through such ab iosynthesis can be used in am odel selection strategy. Another ncAA that allowed for peptidem acrocyclizationi n vivo was O-2-bromomethyltyrosine (O2beY,F igure 2C). [22] O2beYf eatures ab romine as leaving group, whichi sr eadily displaced by an earbyc ysteiner esidue to yield small to medium-sized MPs (n = 1t o9in Figure 2B ). Again, the authors were not only able to demonstrate efficient macrocyclization in vivo, but also showcased the potentialo ft his approach by the design and affinity maturation of aM Pi nhibitor for the sonic hedgehog/patched interaction. [24] The maturedp eptide HL2-m5 Lastly,t he Fasan group also demonstrated that O2beY-mediated macrocyclization is compatible with split intein circular ligation of peptides and proteins (SICLOPPS),awidely employed technique to obtain MPs in vivo. [17, 25, 26] When combined with SICLOPPS,O 2beY incorporationa llowed for the biosynthesis of bicyclic peptides. Aproof-of-principle that the resulting bicyclic peptides are attractive scaffolds for identifying bioactive MPs is providedb yt he biosynthesis of bicyclo-Z8C ( Figure 2D ), which was based on the streptavidin-binding peptided escribed above.C ritically,b icyclo-Z8C showeda2.5-fold lower IC 50 value, when compared to am onocyclic variant, which was attributedt ot he lower conformational flexibility of bicyclo-Z8C. [26] To gether,t hese examples demonstrate that ncAAs are a promisingm eans to access and identify bioactive MPs with novel ring geometries. As the presented strategies enable peptide macrocyclization in vivo, they are now readily availablef or interfacing with phenotypics creens and selection strategies. Thus, future efforts will focus on expanding this methodology to select mono-a nd bicyclic peptides for biologically relevant targets.M oreover,t he introduction of ncAAs other than MeaF and O2beY is likely to make otherc yclization strategies available in the nearf uture. Specifically,n cAAs that enable macrocyclization strategies with sidec hains other than cysteines and transiently formed thioesters are desirable to access "natural product-like" MPs with new ring geometries.
Addiction: ncAAs in Biocontainment
Synthetic biology aims to deploy genetically modified organisms (GMOs) as common and valued solutions in clinical, industrial and environmentals ettings. [27] However, such real-world applicationsn ecessitate the development of biocontainment strategies, reminiscentt ot hose outlined in the 1975 Asilomar conference for recombinant DNA. [28] Generally,e ffective biocontainment strategies must protect againstG MO escape mechanisms, including mutagenic drift, environmental supplementation and horizontal gene transfer. [29] In principle, constructing GMOs with an alternative genetic code by introducingancAA into an essential gene ( Figure 3A ) would advance the barrier betweena ne ngineered and an atural organism, ass urvival of the former would depend on an exogenously supplied synthetic molecule. Therefore, the resulting synthetica uxotrophs could not be rescued by cross-feeding with complex media and horizontal gene transfer would be hampered due to the dependence of the GMO on an alternative genetic code and am atching OTS. However,asynthetic biocontainment constructed by introducing as topc odon in an essential gene can easily be breached by reversion of the introduced nonsense codon or the introduction of ac anonical amino acid instead of the ncAA. In fact, escape frequencies (EFs) for GMOs with as ingle UAG codon at ap ermissive site in an essential protein are % 10
À6
-10 À7 , [29] which does not meet the National Institutes of Health suggested maximumE Fo f 10 À8 . [30] Thus, to achievet ighter containment the need for the synthetic buildingb lock has to be reinforced,f or example, by making protein functions trictly dependent on the incorporation of the ncAA ( Figure 3A) .
Such addiction of protein functiont oas ynthetic amino acid can be achievedb yv ariousm eans. For example, Church and co-workersd esigned synthetic auxotrophs by computationally redesigning hydrophobic interactions in protein cores to exclusively accommodate 4,4'-biphenylalanine (bipA,F igure 3B, C). [31] For the genes of adenylate kinase and tyrosyl-tRNA synthetase this redesign resulted in two separate organisms with low EFs ( % 10
À8
). Moreover,e ngineering as ingle GMO that harbored the identified mutationsf or both genes amplified the effect and resulted in as ynthetica uxotroph for which no escape variants could be detected (EF < 10
À12
). Directed evolution provides another means to redesignt he hydrophobic packing of protein cores to make it depend on a ncAA.S pecifically,t he Ellingtong roup selected TEM-1 b-lactamase variants, the ability of which to confer carbenicillin resistance was dependento nt he introduction of 3-nitrotyrosine (3nY) or 3-iodotyrosine (3iY, Figure 3B) . [32] For apromising engineered variant, TEM-1-B9, phenylalanine was the only canonical amino acid that could rescue the activity in absence of these ncAAs. However,c odons for phenylalanine (UUU and UUC) cannotb ea ccessed by as ingle mutationf rom UAG, thus making this reversion unlikely.T he group confirmed that this is an unlikely escapem echanism by culturing E. coli strains, which harboredT EM-1.B9 and the OTS on as ingle plasmid, continuously in liquid or solid media without detecting any escape variants (EF < 10
À11
). The single plasmids etup is particularly notable, as it allowedf or transformation of other enterobacteriae, whichall becamedependento n3 nY in the presence of ampicillin and did not escape the containment (EF < 10
À9
). Another means for making protein function dependent on the presence of an cAA involves replacement of an atural active site residue with an on-standard one. For example, the Schultz group reported the incorporation of N e -acetyllysine (AcK, Figure 3B )i nto the essential branched chain aminotransferase (BCAT) of E. coli ( Figure 3D) . [33] Specifically,r eplacing a catalytic lysine with AcK will first produce an inactive BCATvariant, which is then activated upon deacetylation by endogenous acetyltransferases in E. coli. As such, synthetic auxotrophs can only breach this containment throughm utations that allow fort he incorporation of lysine in response to the UAG nonsense codon. Indeed, the authors identified this mechanism as the common feature in escape mutants (EF > 10
À8
). Se- quencea nalysis of escape variantsr evealed ap oint mutation in the anticodon of an E. coli lysine tRNA (3'-UUU-5' to 3'-AUU-5'), which resulted in an anticodon that could suppress UAG stop codons through G/U wobble pairf ormation. To counter this escapem echanism, ab arnaseg ene featuring two in-frame UAA stop codons in its mRNA was added to the plasmid. Barnase production is lethal and full-length protein will only be produced in escape variants featuring the mutated lysine tRNA anticodon( 3 '-AUU-5'), which is complementary to the in-frame UAA stop codons. With this conditional kill switch in place escape mutants effectivelyc ommitted suicide, whichr esulted in at ight biocontainment (EF < 10 À11 ). While making protein function dependent on the presence of an cAAi sd esirable, it requires ac ertaind egree of design or evolution. An alternative strategy involves the replacement of conserved residues with an cAA across multiple essential genes. This strategy was showcased by the Isaacs group, who employed multiplex automatedg enomee ngineering (MAGE) [34] to identify as ynthetic auxotropht hat featured three TAGs ites in the MurG, DnaS and SerS genes, as well as an OTS decoding p-azidophenylalanine (pAzF,F igure 3B). [35] In the identified GMO, addiction to pAzF is achieved by the ability of the ncAA to replace conserved aromatic residues in these three genes. Similar to the escape mechanism for AcK-dependent organismsm entioned above though, all escapem utants in this work featured point mutations in the anticodon of one of the three endogenoust yrosine tRNAs. The identified mutations convertedt hem into suppressor tRNAs, resulting in the incorporation of tyrosine insteado fp AzF in response to UAG codons. To overcome this mechanism,the Isaacs group deleted two of the three E. coli tyrosine tRNAs;t he remaining one was therefore essential for tyrosine incorporation in the GMO, preventing it from accumulating mutations and becoming a suppressor tRNA. In addition to as tringent biocontainment (EF < 10
À12
), the authors demonstrated that the resulting synthetic auxotrophc ould not be rescued by cross-feeding and that the alternative geneticc ode indeed impededh orizontal gene transfer. [35] Related to these efforts, introducing multiple stop codons in the genome of viruses is an emerging strategy to generate live but replication-incompetent virus ( Figure 3E) . [36] These can serve as live-attenuated vaccines, as they retain their full infectivity and elicit as trong immune response. Zhou and co-workers, for example, have recentlyc reated ar eplication-incompetent influenzaAvirus, in which multiple UAG codons were introduced at conserved residues throughout the viral genome. [37] Viruses created by this strategy were highly reproductive in transgenic cell lines that featured an OTS to decode UAG codons with N e -2-azidoethyloxycarbonyllysine (AeocK), yet did not show any replication in absence of AeocK (EF < 10
À11
). As anticipated, these engineered influenza As trains generated as trongi mmune responsea gainst both parental and antigenicallyd istinct strains. It is conceivable that this strategyc an be applied to aw ide variety of viruses and replication-incompetentv iruses could not only be used prophylactically as vaccines, but also in diagnostic and therapeutic applications.
Overall, the highlighted examples demonstrate that addiction to ncAAs is ap romising means to create tight biocontainment for synthetic biology applications. [29] Future efforts are likely to expand the number of ncAAs that can be used to create such GMOs and will see their integration into real-world applications. To avoid the use of an expensive ncAA, it is conceivable that endogenousm etabolic pathways could be taken advantage of in order to shift the addiction to am ore cost effective, yet still exogenously-supplied synthetic precursor of an cAA. [38, 39] 
Catalysis:ncAAs in Designer Enzymes
The enzymeo rotidine-5'-phosphate decarboxylase accelerates its target transformation by af actor of 10 17 with respectt ot he uncatalyzed reaction and does so by using only canonical amino acids. [40] However, the scope of enzymecatalysis accessible by standard amino acids is fundamentally limited by the diversityo ff unctional groups presenti nt heir side chains. Therefore, enzymes in nature routinely recruit electrophiles, redox equivalents, metal ions, transfer agents, etc.,i nt he form of cofactors or co-substrates. Similarly,n atural side chains in active sites can undergo posttranslational modificationst oi nstall uniquelyr eactive functional groupst hat promoteadesired transformation (fore xample, converting cysteine to formylglycine in type Isulfatases). [41] Enzymed esign, in part, aims to create proficient protein catalysts with new-to-nature activities. [42, 43] In analogy to the natural strategiesd escribed above, the incorporation of ncAAs into protein scaffolds has emergeda sa na ttractive means to expand the reaction scope of designere nzymes beyondw hat is possible with canonicals ide chains. [44, 45] For example, ncAAs that feature bioorthogonal handles in their side chains can be employed for covalentm odification with abiological, transition metal catalysts (an artificial metalloenzyme,F igure4A). Amongst others, the Lewis group has reported the creationo f ad esigner cyclopropanation enzyme by first introducing pAzF ( Figure 4B )i nto the binding pocket of prolyl oligopeptidase (POP) and then recruiting ad irhodium catalyst through a strain-promoted azide-alkynec ycloaddition. [46] Introducing a bioorthogonal handle (i.e.,t he azide in pAzF) for protein modification is mored esirable than other bioconjugation strategies that rely on naturals idec hains (for example, cysteines), as the modification reaction can be carriedo ut in complex mixtures. [5] This aspect is critical when attempting to evolve artificial metalloenzymes, as anchorings trategies are typically not compatible with the complex cellular milieu. [47] Indeed, the Lewis group has demonstrated the utility of pAzF in the directed evolution of the BOP-derived cyclopropanases. [48] By performing the cofactor anchoringr eaction in bacterial lysates, the group was able to screen libraries of BOP-variants that were generated by random mutagenesis and could successfully identify more proficient cyclopropanases. Additionally,t hese engineered designer enzymes also showed superior reactivity and selectivityi nr elated NÀH, SÀHa nd SiÀHi nsertion reactions. Instead of relying on ab iorthogonal handle to recruit as ynthetic cofactor,t he incorporation of metal-chelating ncAAs that can directly bind metal ions or complexes is another means to create artificial metalloenzymes ( Figure 4C) . [49] For example, the Schultz group installed (2,2'-bipyridin-5-yl)alanine (bpyA, Figure 4B )i nto the E. coli catabolite activatorp rotein, which upon binding of copper or iron ions endowed the protein with nuclease activity. [50] More recently,t he Roelfes group has expandedt his approachb yi ntroducing bpyA into the promiscuous, hydrophobic binding pockets of multidrug resistance regulators (MDRs). Upon binding copper ions, an umber of MDR-based artificial enzymes were created that could catalyzea biological Friedel-Crafts alkylation [51, 52] and hydration reactions. [53] The high activities and selectivities observed in these designer enzymes are the result of embedding the copperi on (through coordination to bpyA) into the MDR binding pockets, which aides in recruiting hydrophobic substrates. Incorporating genetically encodable, metal-chelating ncAAs, such as bpyA, into protein binding pockets is alsoa na ttractive strategyf or future directed evolution campaigns. Am etal-chelating ncAA alleviates the need for ap osttranslationals ynthetic step to recruit the catalysts speciesa nd therefore could facilitate artificial metalloenzyme formationi nc omplex media or even living cells. As ar esult, this strategy could significantly increase the throughput, when screening for improved designer enzymes.
In av ariation of this theme, the Hilvert and Schultz groups have replaced histidine with N d -methyl histidine (NmH)top osition ah eme prosthetic group in myoglobin [54] and an essential zinc ion an mannose-6-phosphate isomerase. [55] While the latter resulted in aG MO addictedt oN mH (EF < 10 À11 ), for the former the introduction of NmH was shown to subtly alter the electronic properties of the bound heme. Notably,i nstalling NmH as axial heme ligand in ap reviously engineered myoglobin [56] did not only boost the peroxidase activity [57, 58] but also its promiscuous cyclopropanationa ctivity. [59] Moreover, in the presence of NmH, cyclopropanation reactions could be carried out in absence of ar educing agent, conditions under which the parent histidine variant was largely inactive. [56] Besides recruiting, positioning and fine-tuning of (synthetic) metal cofactors, the Roelfes group has recently described a new strategy for enzyme design,i nw hich an cAA with a uniquef unctionality is incorporated to act as ac atalytic residue ( Figure 4E ). Specifically,t he incorporation of p-aminophenylalanine (pAF) at position 15 in the MDR from Lactococcus lactis (LmrR), resulted in LmrR_V15pAF,w hich promoted hydrazone and oxime formation reactions. [60] This activity was ascribed to theu niquea bility of the aniline side chain of pAF to form an iminium ion (covalentc atalysis) with an aldehyde substrate,w hich then undergoes at ransimidation reaction in the presence of appropriate hydrazine or hydroxylamine substrates ( Figure 4E ). [61, 62] Critically,t he inherent catalytic activity of anilines to promote this reactionw as boosted by placing pAF in the hydrophobic pore of LmrR. Taking advantage of both the uniquer eactivity of pAF and the ability of LmrR to recruit substrates, LmrR_V15pAF outperformeda niline in solutionb ya factor of % 560. Lastly,inafollow-up study the authors demonstrated that the catalytic contribution of the ncAA can be boosted throughc onsecutive rounds of directed evolution. [63] At otal of four synergistic mutations were identified that, when combined, increased the turnover frequency (k cat )o ft he parent designere nzyme by almost 100-fold and gave rise to variants that outperformed aniline in solution by more than four orders of magnitude.
Overall, these examples demonstrate that the incorporation of ncAAs into protein scaffolds has already begunt os ignificantly expand the reaction scopeo fd esigner enzymes. In the future,p lacing metal-chelating amino acids into protein scaffolds will continue to create new and/or improved metal-binding environments that will give access to new reactivities. For the incorporationo fn cAAs that directly promote at arget transformation,t he creationa nd directed evolution of LmrR_ V15pAFo pens up questions that need to be answered. For example, is it ag eneral phenomenon that the performanceo f organocatalysts, which are versatile yet notoriously slow,i s boosted by placing them in protein scaffolds by ncAA incorporation? [64, 65] And, are the resulting designer enzymes generally privileged starting pointsf or directed evolution efforts, as it was demonstrated for LmrR_pAF? [63] Independent of the answers to these questions, designer enzymes will continuet o make use of ncAAs to catalyze new-to-nature transformations.
Future Directions:Orthogonal Ribosomes
With each sectionc losing with ab rief outline of future directions, this sectiona ims to highlight developments that could impact all areasd iscussed in this Concept article. As mentioned briefly in the Selection part, the simultaneous incorporation of multiple, chemically distinctn cAAs is typically not efficient. [66] This stems from the fact that addingc odons to the existing genetic codei sn ot straightforwarda nd the number of codons readily available for recoding is limited. For example, universal reassignmento fm ore than one nonsense codons is difficult, due to their native functiont os ignal for termination of translation.T om eet this challenge, the Chin group has begun to installaparallel genetic code into model organisms, by making use of orthogonal ribosomes (ORs). [67] In brief, ORs feature mutationsi nthe 16S ribosomal RNA that enables them to recognize mRNAs, which are not translatedb ye ndogenous ribosomes. [68] Conversely,O Rs do not recognize native mRNAs and as ar esult, do not participate in the synthesis of endogenous proteins.B eing now not essential for the survival of the organism,a nO Ri sf ree to accumulate mutationst hat alter its interaction with tRNAs and/or release factors. [69] Such engineering efforts have allowed for the addition of codons, [70] the selection of new OTS that are specific for ORs, [71] andthe efficient encoding of two ncAAs simultaneously. [70, 72] Thus, it is conceivable that applyingO Rs to the strategies discussed in this article could allow for novel peptidem acrocyclization strategies, reinforce synthetic biocontainment, and further expand the scope of reactions catalyzed by designer enzymes.
